"Munich, Germany and Mexico City, Mexico (June 4, 2009) –The Advalytix product team of Olympus, Implen, and AmpliBio jointly  announce that the Mexican Ministry of Agriculture (SAGARPA) awarded AmpliBio a contract for 17 GENE LABs – AmpliBio’s turnkey solution for molecular analysis.  Each GENE LAB will contain Advalytix’s AmpliSpeed single cell molecular analysis cycler, and Implen’s Nanophotometer to quantify DNA, RNA and protein in sub µl samples.  Separately, AmpliBio is supplying the Mexican Institute for Epidemiology (INdRE) with Nanophotometers to increase the institute’s capacity to screen for H1N1.
“Using AmpliSpeed cyclers and AmpliGrid slides we plan to screen fish and shrimp eggs imported to Mexico for over 20 viral and bacterial pathogens. AmpliGrid slides greatly simplify single cell handling, allow us to detect minute amounts of pathogen, and save reagents due to their 1µl reaction volumes,” said Biol. Ernesto Ontiveros, representative of SAGARPA..."

The 1st Workshop on single cell qPCR was held successfully on 08 - 10 December 2008 at BioEPS/ TATAA Biocenter Germany in Freising, Germany, initiated by BioEPS and the Advalytix product team of Olympus. This 3-day workshop provided a comprehensive overview of single-cell and qPCR technology, starting from cell selection to final qPCR analysis.

Olympus Life Science Research Europa GmbH is among the proud winners of the Innovation Competition 2008 awarded by the German Federal Ministry of Education and Research. In collaboration with PD Dr. Udo Markert, head of the Placenta Lab of the University Hospital Jena, researchers of the Advalytix products team of Olympus Life Science Research Europa GmbH have developed a method that may be developed into a clinical test that would allow for the  non-invasive detection of embryonic genetic diseases. 

Solana Beach, Calif., Hamilton, New Zealand and Munich, Germany – October 14, 2008–ZyGEM Corp. Ltd. today announced that it has entered into an agreement with the Advalytix product team of Olympus Life Science Research Europa GmbH to produce a private-label line of DNA extraction products.  The collaboration will combine ZyGEM’s advanced enzymatic nucleic acid extraction technology and Advalytix’s expertise in single-cell molecular tests for life science research applications.

Munich, Germany (September 10, 2008) - The Advalytix product team of Olympus is initiating a collaborative study with The University of Texas M. D. Anderson Cancer Center to characterize circulating tumor cells in breast cancer patients. The study combines Advalytix’s sensitive AmpliGrid molecular analysis platform, multiplex primer design, and integrated workflow to analyze expression of multiple target genes in single tumor cells.

Munich, Germany (June 24, 2008) –The Advalytix product team of Olympus is launching a certification program for flow cytometry facilities who have demonstrated > 90% success rate of placing single cells into the reaction sites on Advalytix’ 1µl AmpliGrid PCR slides.  Among the first to achieve certification are flow cytometry facilities located at the Brigham & Women’s Hospital, Boston, MA; UMass Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; Creighton University, Omaha, NE; Duke University Human Vaccine Institute, Durham, NC; UNC at Chapel Hill; MD Anderson Cancer Center, Houston, TX; NIH’s NHLBI and NCI,  Bethesda, MD; the Gladstone Institutes, San Francisco, CA, Stanford University, Palo Alto, CA and the German Rheumatism Research Center, Berlin, Germany.

Munich, Germany (May 14, 2008) – The Advalytix products team of Olympus introduces the CellEvator mixer, which uses proprietary surface acoustic wave (SAW) mixing technology to enhance sample mixing during cell sorting. The CellEvator is a drop-in replacement for the built-in mechanical sample mixer in Becton Dickinson’s  FACSAria™ cell sorting system. It will be on exhibit at the 24th Annual International Congress of the International Society of Analytical Cytology, Booth 41, May 17-21, in Budapest, Hungary.

Munich, 31.03.2008 – The Advalytix product range is enabling researchers at the University Hospital of Jena to revolutionize strategies in breast cancer research. The unique AmpliGrid AG480F and AmpliSpeed single cell amplification system has ensured that, for the first time, scientists can ‘type’ and ‘profile’ each individual circulating cell in a enriched mixture using PCR or RT-PCR protocols. This means that cancer cells can be compared to normal cells very easily and quickly.

November 2007 – Just a few months after the launch of the new company website, Advalytix now presents the Advalytix Newsletter. The focus is to provide all Advalytix customers with first-rate application reports from academia and industry. Complemented with special protocols for the AmpliGrid system as well as information on new products, customer-related company news and upcoming events the newsletter also offers the opportunity to stay up-to-date with Advalytix.
Take a look at the first issue of the Advalytix Newsletter and read an exciting white paper centring on memory B cells and vaccines. Find out how Dr. Colette Cywes Bentley of the Harvard Medical School uses single-cell molecular analysis to discover how viral infection predisposes people to bacterial super-infections. Simply sign up here and receive all issues free of charge directly via e-mail.

Munich, May 2007 – Advalytix AG, a subsidiary of Olympus Life and Material Science Europa GmbH, and the Medical University of Graz are cooperating on novel prenatal research technologies. Together they are testing a new method for the genetic analysis of fetal cells from maternal blood.